Moving Targets

Good afternoon!! Moving Targets 2019 is two months away!

The AAPS-USC Student Chapter invites you to join us at our annual Moving Targets scientific research symposium on Friday, August 23rd, 2019 at The USC Hotel in Los Angeles, CA. Our 18th annual symposium is titled "Artificial Intelligence, Real Solutions: How Big Data is Revolutionizing Medicine from Bench to Bedside." This one-day research symposium will focus on applications of big data analysis to improve various aspects of medicine, from drug development to healthcare.

Registration is required and is FREE for all USC students, faculty, staff, and alumni. All others must pay a $50 registration fee. The research symposium will be followed by a networking mixer which will include food, cocktails, and an opportunity to network with our speakers for only $10. Please follow this link to RSVP for the event and purchase tickets to the networking mixer: http://www.movingtargets.la/rsvp

There will be a poster session, which is open to all attendees, regardless of research area. Please submit an abstract with a maximum of 500 words by Friday, August 9th. Top poster presentations will receive cash prizes! Follow this link to submit your abstract: http://www.movingtargets.la/poster-submission-3

For more information about Moving Targets, please visit our website: http://www.movingtargets.la/

We can't wait to see you all there :)

This year’s Moving Targets will be held on this Friday!!! Check out our website www.movingtargets.la. for more detail. Our last speaker for Moving Targets 2018 is Dr. Richard Fond.

Dr. Fond attended UCLA as an undergraduate before being admitted to the doctor of pharmacy program at the University of Southern California School of Pharmacy. He practiced in community pharmacy settings for forty-one years, where he often mentored students, including pharmacy interns and technicians. He owned and operated the Glenoaks Rx Pharmacy in Burbank, CA from 1972 until 2006. From 1985 to 1992 he partnered in the ownership of Karen Pharmacy, also located in Burbank. Dr. Fond served on the board of the Pharmacists’ Society of the San Fernando Valley for fifteen years and as an officer for ten years. In 2015, Dr. Fond was granted a life membership in The California Pharmacist Association at its annual convention, at which he was a frequent delegate. In 2015 he was also honored by the California State Board of Pharmacy in recognition of his 50 years of registration and service to the public. Dr. Fond proposed to the Pharmacy Board at its March meeting this year that it published in its online newsletter, The Script, an article that he had written titled “I Am a Drug Addict,” (based on the narcotic withdrawal symptoms he experienced after only one week post-surgery from the dosing of a medically prescribed opioid) as one means of helping to raise the awareness of licensees regarding the national crisis of opioid addiction, through the telling of his personal story.

Good morning everyone! This is the last call for the poster session, the submission entrance will be closed TONIGHT!!! Check out our website www.movingtargets.la. for RSVP and more detail information about poster session. Our sixth speaker for Moving targets 2018 is Dr. Scott Mosley.
Dr. Mosley's research is focused on the implementation of pharmacogenomics, which incorporates genetic information with other clinical factors to optimize drug selection. His expertise in pharmacogenomics implementation will accelerate efforts in applying genetic information to improving the efficacy and safety of medications for our patients. Mosley received a B.S. in Biochemical/Biophysical Science from the University of Houston in 2006, then worked for three years in a core pharmacology lab as an analytical chemist for MD Anderson Cancer Center in Houston. He received his PharmD degree from the University of Texas in 2013, and then took a position as a pharmacist with MD Anderson Cancer Center. He recently completed a postdoctoral research fellowship at the University of Florida College of Pharmacy in the Center for Pharmacogenomics under the mentorship of Larisa Cavallari, PharmD. Dr. Mosley joined the faculty of the Titus Department of Clinical Pharmacy as assistant professor of clinical pharmacy at USC.

Good morning everyone! Only one day away from the deadline for abstract submission! Check out our website www.movingtargets.la. for RSVP and more detail information about poster session. Our fifth speaker for Moving targets 2018 is Dr. Melissa Durham

Dr. Durham is an Assistant Professor of Clinical Pharmacy at the University of Southern California (USC) School of Pharmacy. She received her Doctor of Pharmacy degree, completed a residency in Community Pharmacy Practice, and has earned her Master’s degree in Academic Medicine, all from USC. Dr. Durham is a clinical pharmacist at the USC Pain Center in the Department of Anesthesiology, where she established a pharmacist-run pain medication management service. She is a Board Certified Ambulatory Care Pharmacist and a Diplomat of the Academy of Integrative Pain Management. In addition, she is a practicing community pharmacist.

Hello everyone! Just a reminder for everyone who wants to join the poster session, this Friday will be the last day for abstract submission! Here’s good news, for non-USC students who sign up for the poster session can waive the RSVP fee ($50)! Check out our website for more information www.movingtargets.la. Our fourth speaker for Moving targets 2018 is Dr. Chitra Mandyam

Dr. Mandyam graduated from the College of Pharmacy at the University of Houston with a Ph.D. in pharmacological sciences and continued her postdoctoral research at the department of psychiatry at UT Southwestern Medical Center in neuroscience with a focus on addiction research. She later moved to San Diego, and after her tenure at the Scripps Research Institute, she moved her laboratory to University of California San Diego where she is an associate professor with joint appointments at the department of anesthesiology and Skaggs School of Pharmacy. She is also a research biologist at the VA San Diego Healthcare System. The general goal of her laboratory is to understand the relationship between brain structure and function using state-of-the-art molecular and cellular approaches to study high-level mental functions such as illicit drug/alcohol taking and seeking. Her lab employs genetic, pharmacological, electrophysiological and histochemical techniques and behavioral paradigms for understanding the role of neural stem cells and myelinating oligodendrocytes in neuropathology produced by illicit drug/alcohol use. These studies in her lab may reveal novel neuroprotective strategies to reduce the propensity of relapse to drug use. Dr. Mandyam is a member at Neurobiology of Motivated Behavior Study Section at NIH and a member of the American College of Neuropsychopharmacology and serves as a reviewer of several journals.

Greeting! Moving targets 2018 is only 3 weeks away! Check out our website www.movingtargets.la to RSVP and submit your abstract for the poster session. The winner will get $500 prize. Our third speaker for Moving targets 2018 is Dr. Brian Shoichet.

Dr. Shoichet serves as a professor in the Department of Pharmaceutical Chemistry at UC, San Francisco. From 1996 to 2002, he joined the faculty at Northwestern University in the Department of Molecular Pharmacology & Biological Chemistry and was recruited back to UCSF in 2003. His postdoctoral research focused on protein structure and stability with Brian Matthews at the Institute of Molecular Biology in Eugene, Oregon, as a Damon Runyon Fellow. He received his Ph.D. for work with Tack K***z on molecular docking in 1991 from UCSF. His current work focuses on taking computational approaches to develop an opioid that has potent analgesic properties with reduced addictive potential. Research in the Shoichet Lab seeks to bring chemical reagents to biology, combining computational simulation and experiment. Broadly, the Shoichet Lab adopts a protein-centric approach that seeks new ligands to complement protein structures. Using a ligand-centric approach, his lab seeks new targets for established drugs and reagents. Whereas this lacks the physical foundation of the structure-based research program, it returns to an older, pharmacological view of biological relationships, bringing to it a quantitative model. A focus for both approaches is ligand discovery against G Protein-Coupled Receptors (GPCRs).

Greeting! Moving Targets 2018 is only 4 weeks away. Check out our website www.movingtargets.la to RSVP and join the poster session! Our second speaker for Moving Targets 2018 is Dr.Pacula.

Dr. Pacula is a senior economist at the RAND Corporation and a professor at the Pardee RAND Graduate School. She serves as director of RAND's BING Center for Health Economics and co-director of the RAND Drug Policy Research Center. Her research at RAND over the last 20 years has largely focused on issues related to illegal or imperfect markets (healthcare markets, insurance markets, illicit drug markets), measurement of the size of these markets, the impact they have on behavior (suppliers and consumers), and the effectiveness of policy interventions at targeting behavior within these markets. More recently her work has shifted to evaluating the impact of recent opioid policies in the US. She has explored the influence of buprenorphine diffusion, OxyContin reformulation, insurance expansion, medical ma*****na and naloxone distribution laws on opioid-related harm. She has also done work examining the size of the market for illicit opioids. Pacula has been a member of the National Bureau of Economic Research (NBER) since 1997, serves on the editorial board of several journals, and is a scientific reviewer for the National Institutes of Health's HSOD committee. She received her Ph.D. in economics from Duke University.

Hello everyone, a weekend is coming! Moving Targets 2018 is only 5 weeks away. Have you registered for the meeting or the poster session, check out our website at www.movingtargets.la! In the next few weeks, we are very pleasured to introduce our speakers. The first speaker for moving targets 2018 is Dr. Kim Janda.

Dr. Kim Janda works in Scripps Research Institute, the Skagges Institute for Chemical Biology. His work encompasses the design/synthesis and evaluation of catalytic antibodies and enzyme inhibitors, solid-phase organic synthesis, the application of immunopharmacotherapy in the treatment of drug addiction and cancer, methods of prevention and treatment of obesity, diagnostic and therapeutic strategies towards neglected tropical diseases and other several areas.

Over the last twenty years, antibody catalysis has traversed many different paths. Throughout this time, Dr. Kim Janda’s team have pioneered various strategies beyond transition state analogues for eliciting catalytic antibodies, they continue to push the boundaries of what is believed possible using catalytic antibodies and remain a major contributor to this field as it continues to evolve. Examples of current projects in this area include harnessing the power of the intrinsic antibody oxidation potential for the catalytic degradation of biologically relevant molecules, the design of novel haptens for elimination reactions relevant to drugs of abuse, and explorations of blue-fluorescent antibody technology in biological applications.

The AAPS-USC student Chapter invites you to join us at Moving Targets 2018: Pain Management!

The 17th annual Moving Targets symposium will focus on the advancements in the field of pain medicine and new therapeutic strategies to combat the opioid crisis. Our speakers from different backgrounds in the field of pain medicine will give presentations span across the basic and translational sciences, regulatory activities, and policymaking.

At meanwhile, a graduate student poster session will also be held, and we are now accepting posters from all fields of researches. Feel free to join us and win the prize!

Scan the QR codes below to RSVP or submit your poster from today!

The Moving Targets 2018 will be held on August 17th, 2018 at the Aresty Conference Center (NRT) on 1450 Biggy Street, Los Angeles, CA 90033

Keep following us on Facebook, we will post more information about our speakers. For more information on the event, please head to www.movingtargets.la or contact us at [email protected].

Moving Targets is today! Come to the Radisson Hotel at USC!

Have you submitted your abstract? We accept abstracts from all fields! Use our online submission form www.movingtargets.la/poster-submission to submit an abstract to present your poster at the symposium!

Our last speaker is Dr. Hesham A. Abdullah.

Hesham A. Abdullah is Vice President, Global Regulatory Affairs, Oncology & Immuno-Oncology at AstraZeneca Pharmaceuticals. Dr. Abdullah is a seasoned clinician and regulatory professional with more than 15 years of clinical, drug development and global regulatory sciences oncology experience. He has an established track record of leading programs and portfolios, from a strategic regulatory perspective, from early to late stages of development and registration. Dr. Abdullah possesses both small and large molecule Oncology and Immuno-Oncology expertise. He has overseen the global registration of multiple targeted therapeutics, across various solid tumors, including Imfinzi™, Tagrisso®, Lynparza™ and Iressa®. He has established science based and collaborative relationships with global health authorities and is recognized as an influential figure with key stakeholders. His ability to integrate precision medicine and regulatory science is a unique capability that has contributed to his leadership in developing novel and innovative regulatory strategies for oncology therapeutics. Dr. Abdullah holds a Doctorate of Medicine (MD) and Master’s of Regulatory Sciences (MSc) degree. Additionally, he is currently a candidate for a Doctorate degree in Regulatory Sciences (DRSc) at the University of Southern California (USC).